Source: EURLEX
Language: en
Format: md

|  |  |  |
| --- | --- | --- |
| European flag | Official Journal  of the European Union | EN  C series |

---

|  |  |  |
| --- | --- | --- |
|  | C/2024/6439 | 4.11.2024 |

Order of the General Court of 19 September 2024 – Laboratorios Salvat v EUIPO – Acta Farma (Omycol)

(Case T-264/24)
 [(1)](#ntr1-C_202406439EN.000101-E0001)

(EU trade mark - Opposition proceedings - Withdrawal of the opposition - No need to adjudicate)

(C/2024/6439)

Language of the case: Spanish

Parties

Applicant: Laboratorios Salvat, SA (Esplugues de Llobregat, Spain) (represented by: J. Güell Serra, lawyer)

Defendant: European Union Intellectual Property Office (represented by: E. Nicolás Gómez, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO: Acta Farma, SL (Alcorcón, Spain)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment of the decision of the Fifth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 12 March 2024 (Case R 1638/2023-5).

Operative part of the order

|  |  |
| --- | --- |
| 1. | There is no longer any need to adjudicate on the action. |

|  |  |
| --- | --- |
| 2. | Laboratorios Salvat, SA shall bear its own costs and pay the costs incurred by the European Union Intellectual Property Office (EUIPO). |

---

---

ELI: http://data.europa.eu/eli/C/2024/6439/oj

ISSN 1977-091X (electronic edition)

---

[Top](#document1)